{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:51:22Z","timestamp":1790704282217,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12906-016-1372-x","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T13:26:40Z","timestamp":1476797200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["An assessment of the impact of herb-drug combinations used by cancer patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Saud M.","family":"Alsanad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2710.2002.00444.x","volume":"27","author":"W Abebe","year":"2002","unstructured":"Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27:391\u2013401.","journal-title":"J Clin Pharm Ther"},{"key":"1372_CR2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ctcp.2010.05.001","volume":"16","author":"FU Afifi","year":"2010","unstructured":"Afifi FU, Wazaify M, Jabr M, Treish E. The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complement Ther Clin Pract. 2010;16:208\u201312.","journal-title":"Complement Ther Clin Pract"},{"key":"1372_CR3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ptr.5213","volume":"28","author":"SM Alsanad","year":"2014","unstructured":"Alsanad SM, Williamson EM, Howard RL. Cancer patients at risk of herb\/food supplement\u2013drug interactions: a systematic review. Phytother Res. 2014;28:1749\u201355.","journal-title":"Phytother Res"},{"key":"1372_CR4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/mds.20632","volume":"20","author":"P Champy","year":"2005","unstructured":"Champy P, Melot A, Gu\u00e9rineau Eng V, Gleye C, Fall D, H\u00f6glinger GU, Ruberg M, Lannuzel A, Lapr\u00e9vote O, Laurens A, Hocquemiller R. Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in Guadeloupe. Mov Disord. 2005;20:1629\u201333.","journal-title":"Mov Disord"},{"key":"1372_CR5","first-page":"875","volume":"116","author":"K Chrystal","year":"2003","unstructured":"Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary\/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. NZ Med J. 2003;116:875\u2013903.","journal-title":"NZ Med J"},{"key":"1372_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/B:BREA.0000025422.26148.8d","volume":"85","author":"Y Cui","year":"2004","unstructured":"Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263\u201370.","journal-title":"Breast Cancer Res Treat"},{"key":"1372_CR7","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0959-8049(03)00604-X","volume":"39","author":"E Ernst","year":"2003","unstructured":"Ernst E. The current position of complementary\/alternative medicine in cancer. Eur J Cancer. 2003;39:2273\u20137.","journal-title":"Eur J Cancer"},{"key":"1372_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1534735408330202","volume":"8","author":"S Engdal","year":"2009","unstructured":"Engdal S, Klepp O, Nilsen OG. Identification and exploration of herb-drug combinations used by cancer patients. Integr Cancer Ther. 2009;8:29\u201336.","journal-title":"Integr Cancer Ther"},{"key":"1372_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","volume":"52","author":"A Fugh-Berman","year":"2001","unstructured":"Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol. 2001;52:587\u201395.","journal-title":"Br J Clin Pharmacol"},{"key":"1372_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/clpt.2014.18","volume":"95","author":"A Goey","year":"2014","unstructured":"Goey A, Beijnen J, Schellens J. Herb\u2013Drug Interactions in Oncology. Clin Pharmacol Ther. 2014;95:354\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"1372_CR11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcp137","volume":"102","author":"C Gratus","year":"2009","unstructured":"Gratus C, Damery S, Wilson S, Warmington S, Routledge P, Grieve R, Steven N, Jones J, Greenfield S. The use of herbal medicines by people with cancer in the UK: a systematic review of the literature. QJM. 2009;102:831\u201342.","journal-title":"QJM"},{"key":"1372_CR12","volume-title":"Fundamentals of Pharmacognosy and Phytotherapy","author":"M Heinrich","year":"2012","unstructured":"Heinrich M, Barnes J, Gibbons S, Williamson EM. Fundamentals of Pharmacognosy and Phytotherapy. 2012. Elsevier Health Sciences."},{"issue":"13","key":"1372_CR13","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1055\/s-0032-1315117","volume":"78","author":"R Hermann","year":"2012","unstructured":"Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med. 2012;78(13):1458\u201377.","journal-title":"Planta Med"},{"key":"1372_CR14","first-page":"79","volume":"65","author":"J H\u00fcbner","year":"2013","unstructured":"H\u00fcbner J. Complementary and alternative medicine in oncology. Versicherungsmedizin. 2013;65:79\u201383.","journal-title":"Versicherungsmedizin"},{"key":"1372_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000334488","volume":"21","author":"AA Izzo","year":"2012","unstructured":"Izzo AA. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012;21:404\u201328.","journal-title":"Med Princ Pract"},{"key":"1372_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ptr.5591","volume":"30","author":"AA Izzo","year":"2016","unstructured":"Izzo AA, Kim SH, Radhakrishnan R, Williamson EM. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of commonly used herbal remedies. Phytother Res. 2016;30:691\u2013700.","journal-title":"Phytother Res"},{"key":"1372_CR17","doi-asserted-by":"crossref","first-page":"879396","DOI":"10.1155\/2014\/879396","volume":"2014","author":"O Kelber","year":"2014","unstructured":"Kelber O, Nieber K, Kraft K. Valerian: no evidence for clinically relevant interactions. Evid Based Complement Alternat Med. 2014;2014:879396.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1372_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.coc.0000209369.44100.25","volume":"29","author":"AH Lee","year":"2006","unstructured":"Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J Clin Oncol. 2006;29:178\u201382.","journal-title":"Am J Clin Oncol"},{"key":"1372_CR19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","volume":"94","author":"RH Mathijssen","year":"2002","unstructured":"Mathijssen RH, Verweij J, DE Bruijn P, Loos WJ, Sparreboom A. Effects of St. John\u2019s wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94:1247\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1372_CR20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00520-004-0598-1","volume":"12","author":"JS McCune","year":"2004","unstructured":"McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004;12:454\u201362.","journal-title":"Support Care Cancer"},{"key":"1372_CR21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00228-011-1181-6","volume":"68","author":"J Mclay","year":"2012","unstructured":"Mclay J, Stewart D, George J, Rore C, Heys S. Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol. 2012;68:811\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"1372_CR22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1634\/theoncologist.11-7-742","volume":"11","author":"I Meijerman","year":"2006","unstructured":"Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006;11:742\u201352.","journal-title":"Oncologist"},{"key":"1372_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ctcp.2005.09.007","volume":"12","author":"A Molassiotis","year":"2006","unstructured":"Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E, Browall M, Fernandez-Ortega P, Pud D, Margulies A. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract. 2006;12:34\u20139.","journal-title":"Complement Ther Clin Pract"},{"key":"1372_CR24","volume-title":"Evidence-based herbal medicine","author":"M Rotblatt","year":"2002","unstructured":"Rotblatt M, Ziment I. Evidence-based herbal medicine. Philadelphia: Hanley & Belfus; 2002."},{"key":"1372_CR25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ptr.5050","volume":"28","author":"E Russo","year":"2014","unstructured":"Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patan\u00e8 M, Upton R, Pugliese M, Chimirri S. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug\u2013drug interactions. Phytother Res. 2014;28:643\u201355.","journal-title":"Phytother Res"},{"key":"1372_CR26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0196-0644(98)70077-0","volume":"32","author":"JR Suchard","year":"1998","unstructured":"Suchard JR, Wallace KL, Gerkin RD. Acute cyanide toxicity caused by apricot kernel ingestion. Ann Emerg Med. 1998;32:742\u20134.","journal-title":"Ann Emerg Med"},{"key":"1372_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/dmd.104.002485","volume":"33","author":"R Tian","year":"2005","unstructured":"Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. Functional induction and de-induction of P-glycoprotein by St. John\u2019s wort and its ingredients in a human colon adenocarcinoma cell line. Drug Metab Dispos. 2005;33:547\u201354.","journal-title":"Drug Metab Dispos"},{"key":"1372_CR28","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0003-4967(24)42841-0","volume":"64","author":"M Thomsen","year":"2005","unstructured":"Thomsen M, Schmidt M, Vitetta L, Sali A. Do herbs increase the risk of herb\u2013drug interactions for patients with arthritis? Ann Rheumatic Dis. 2005;64:1527\u201328.","journal-title":"Ann Rheumatic Dis"},{"key":"1372_CR29","first-page":"32","volume":"83","author":"S Tuna","year":"2011","unstructured":"Tuna S, Dizdar O, Calis M. The prevalence of usage of herbal medicines among cancer patients. System. 2011;83:32.","journal-title":"System"},{"key":"1372_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1472-6882-6-40","volume":"6","author":"KA Vickers","year":"2006","unstructured":"Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women\u2019s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6:40.","journal-title":"BMC Complement Altern Med"},{"key":"1372_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","volume":"90","author":"U Werneke","year":"2004","unstructured":"Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90:408\u201313.","journal-title":"Br J Cancer"},{"key":"1372_CR32","unstructured":"WHO. Traditional medicine strategy: 2014\u20132023 [Online]. World Health Organization; 2013. Available: http:\/\/www.who.int\/medicines\/publications\/traditional\/trm_strategy14_23\/ . Accessed 21 Apr 2016."},{"key":"1372_CR33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/14740338.4.2.355","volume":"4","author":"EM Williamson","year":"2005","unstructured":"Williamson EM. Interactions between herbal and conventional medicines. Expert Opin Drug Saf. 2005;4:355\u201378.","journal-title":"Expert Opin Drug Saf"},{"key":"1372_CR34","volume-title":"Stockley\u2019s Herbal Medicine\u2019s Interactions: a guide to the interactions of herbal medicines","author":"EM Williamson","year":"2013","unstructured":"Williamson EM, Driver SB, Baxter K, Lee CR. Stockley\u2019s Herbal Medicine\u2019s Interactions: a guide to the interactions of herbal medicines. London: Pharmaceutical Press; 2013."},{"key":"1372_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jada.2004.11.002","volume":"105","author":"RS Wold","year":"2005","unstructured":"Wold RS, Lopez ST, Yau CL, Butler LM, Pareo-Tubbeh SL, Waters DL, Garry PJ, Baumgartner RN. Increasing trends in elderly persons\u2019 use of non-vitamin, non-mineral dietary supplements and concurrent use of medications. J Am Diet Assoc. 2005;105:54\u201363.","journal-title":"J Am Diet Assoc"},{"key":"1372_CR36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cancers3010773","volume":"3","author":"R Zachariae","year":"2011","unstructured":"Zachariae R, Johannessen H. A methodological framework for evaluating the evidence for Complementary and Alternative Medicine (CAM) for cancer. Cancers. 2011;3:773\u201388.","journal-title":"Cancers"},{"key":"1372_CR37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00432-012-1336-6","volume":"139","author":"T Zeller","year":"2013","unstructured":"Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Becker S, Serve H, Huebner J. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin. 2013;139:357\u201365.","journal-title":"J Cancer Res Clin"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T16:30:52Z","timestamp":1749659452000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-016-1372-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1186\/s12906-016-1372-x","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"article-number":"393"}}